Bibi Oncology Services Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 14.35 Cr
- Company Age 9 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.70 Cr
- Revenue Growth -16.70%
- Profit Growth -39.76%
- Ebitda -323.24%
- Net Worth -14.02%
- Total Assets -16.84%
About Bibi Oncology Services
Bibi Oncology Services Private Limited (BOSPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 March 2015 (Nine years and ten months 28 days old ). Its registered office is in Thiruvananthapuram, Kerala, India.
The Corporate was formerly known as Bibi Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 14.35 Cr.
The company currently has active open charges totaling ₹12.70 Cr.
Faiz Bano, Syed Farees, Khatija Syed, and One other member serve as directors at the Company.
Company Details
- Location
Thiruvananthapuram, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900KL2015PTC047520
- Company No.
047520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Bibi Oncology Services?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Faiz Bano  | Director | 05-Jul-2022 | Current |
| Syed Farees | Director | 04-May-2021 | Current |
Khatija Syed  | Additional Director | 04-May-2021 | Current |
| Nisar Syed | Director | 26-Mar-2015 | Current |
Financial Performance of Bibi Oncology Services.
Bibi Oncology Services Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.7% decrease. The company also saw a substantial fall in profitability, with a 39.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 14.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bibi Oncology Services?
In 2023, Bibi Oncology Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- American Super Speciality Hospitals Private Limited
Syed Farees is a mutual person
Charges (Loans)
₹12.70 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 12.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Feb 2018 | Hdfc Bank Limited | ₹2.00 Cr | Open |
| 25 Jul 2016 | Hdfc Bank Limited | ₹2.30 Cr | Open |
| 05 Feb 2016 | Hdfc Bank Limited | ₹8.40 Cr | Open |
How Many Employees Work at Bibi Oncology Services?
Bibi Oncology Services has a workforce of 38 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bibi Oncology Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bibi Oncology Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
